References
Sears, M. R., Taylor, D. R., Purist, C. G., Lake, D. C., Li, Q., Flannery, E. M., Yates, D. E., Lucas, M. K., and Herbison, G. P. (1990),Lancet 336, 1391–1396.
Van Schayck, C. P., Dompeling, E., Van Herwaarden, C. L. A., Folgering, H., Verbeek, A. L. M., van de Hoogen, H. J. M., and van Weel, C. (1991),Br. Med. J. 303, 1426–1430.
Nials, A. T., Coleman, R. A., Johnson, M., Magnussen, H., Rabe, K. F., and Vardy, C. F. (1993),Br. J. Pharmacol. 110, 1112–1116.
Ariens, E. J. (1993),Trends Pharmacol. Sci. 14, 68–70.
Conolly, M. E., Davis, D. S., Dollery, C. T., and George, C. F. (1971),Br. J. Pharmacol. 43, 389–402.
Mazzoni, L., Morley, J., Page, C. P., and Sanjar, S. (1985),Br. J. Pharmacol. 86, 571P.86, 571P.
Sanjar, S., Kristersson, A., Mazzoni, L., Morley, J., and Schaeubtin, E. (1990),J. Physiol. 425, 43–54.
Chapman, I., Mazzoni, L., and Morley, J. (1990),Br. J. Pharmacol. 99, 66P.
Hoshiko, K., and Morley, J. (1993),Jpn. J. Pharmacol. 63, 159–163.
Witt-Enderby, P. A., Yamarniura, H. I., Halonen, M., Palmer, J. D., and Bloom, J. W. (1993),Eur. J. Pharmacol. 241, 121–123.
Wang, Z. L., Bramiey, A. M., McNamara, A., Pare, P. D., and Bai, T. R. (1994),Am. J. Respir. Crit. Care Med. 149, 960–965.
Fugner, R. A. (1985), inPulmonary and Antiallergic Drugs, Delvin, J. P., ed., Wiley, New York, pp. 123–190.
Grundström, N., Andersson, R. G. G., and Wikberg, J. E. S. (1981),Acta. Pharmacol. Toxicol. 49, 150–157.
Morley, J., Chapman, I. D., Foster, A., Hoshiko, K., and Mazzoni, L. (1991),Br. J. Pharmacol. 104, 295P.
Galland, B. C. and Blackman, J. G. (1989),New Z. Med. J. 102, 226–231.
Gavett, S. H. and Marsha, W. (1993),Am. J. Physiol. 265, L493-L500.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Johansson, F., Rydberg, I., Aberg, G. et al. Effects of albuterol enantiomers on in vitro bronchial reactivity. Clinic Rev Allerg Immunol 14, 57–64 (1996). https://doi.org/10.1007/BF02772203
Issue Date:
DOI: https://doi.org/10.1007/BF02772203